Breath Diagnostics' mission is to globally implement breath analysis technology to provide early detection for cancers
Breath Diagnostics's mission is to globally implement breath analysis technology to provide early detection for cancers and reduce patient exposure to costly, high risk medical procedures.They have developed a patented technology that will determine if a patient has lung cancer by analyzing a patient’s breath with parts per billion accuracy, allowing very early detection. They have studied over 700 patients. This has the potential to save a significant number of lives and save the healthcare industry significant dollars.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 11, 2016 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |